These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15647070)

  • 1. DCIS: use of biomarkers and morphology to predict concurrent invasion.
    Lagios MD
    Breast J; 2005; 11(1):1. PubMed ID: 15647070
    [No Abstract]   [Full Text] [Related]  

  • 2. Biology of ductal carcinoma in situ classification based on biologic potential.
    Tsikitis VL; Chung MA
    Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological variables and prognosis of DCIS.
    van de Vijver MJ
    Breast; 2005 Dec; 14(6):509-19. PubMed ID: 16246564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 6. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microinvasive carcinoma of the breast: a diagnosis in search of a definition.
    Schnitt SJ
    Adv Anat Pathol; 1998 Nov; 5(6):367-72. PubMed ID: 10095878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery].
    Bässler R
    Strahlenther Onkol; 1996 Feb; 172(2):110-1. PubMed ID: 8669044
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
    Wiechmann L; Kuerer HM
    Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between nuclear grade of ductal carcinoma in situ and cell origin markers.
    Tang P; Wang X; Schiffhauer L; Wang J; Bourne P; Yang Q; Quinn A; Hajdu SI
    Ann Clin Lab Sci; 2006; 36(1):16-22. PubMed ID: 16501232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
    Wilkie C; White L; Dupont E; Cantor A; Cox CE
    Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.
    Esposito NN; Dabbs DJ; Bhargava R
    Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory breast carcinoma with extensive intraductal component: case report.
    Celik A; Kutun S; Pak I; Seki A; Cetin A
    Ultrastruct Pathol; 2004; 28(5-6):361-3. PubMed ID: 15764584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological and cell biological characteristics of ductal carcinoma in situ (DCIS) of the breast-a comparison between the primary DCIS and subsequent ipsilateral and contralateral tumours.
    Idvall I; Ringberg A; Anderson H; Akerman M; Fernö M
    Breast; 2005 Aug; 14(4):290-7. PubMed ID: 16085235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
    Sanders ME; Schuyler PA; Dupont WD; Page DL
    Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.